Alteplase for Acute Ischemic Stroke and Subgroups | Journal Scan

Study Questions:

What are the factors that modify the benefits (improvement in functional outcome at 6 months) or hazards (early symptomatic intracranial hemorrhage defined as those events occurring within 7 days; or early death, defined as those occurring within 7 days) when treated with alteplase for acute ischemic stroke?